Insanely related: Do mobile phones have anything to do with cancer?

I was just sent THIS article, which claims that a new study does show a link between brain cancer and cell phones:

This new study has been published in the International Journal of Oncology. They concluded that there was a significantly increased risk for glioma from the long-term use of a mobile or cordless phone.

The risk increased with latency time and cumulative use in hours and was highest in subjects with first use before the age of 20 - in this group there was almost 5 times the risk after 10 years mobile phone use.

The abstract for the referenced study, published in May 2011, is HERE, and features this quote:

In conclusion, an increased risk was found for glioma and use of mobile or cordless phone. The risk increased with latency time and cumulative use in hours and was highest in subjects with first use before the age of 20.

Now, I realize that the related post clearly has an answer citing THIS study which found no correlation. This new study, however, is five years more recent and is a peer reviewed article concluding that there is a correlation.

Thus, I saw value in a question for this new evidence, and I'm specifically looking for answers to these questions:

  • Does this new paper bring legitimate, solid new evidence to the table on this issue?
  • If it does bring evidence forward, can someone explain exactly what the implications are? As in, perhaps it is similar to the answer in the original question on cell phones/cancer in which it was pointed out that the WHO's rating of cell phones as a 2B carcinogen was nothing to be concerned about after all.
  • If it does not, is anyone able to explain why by critiquing the methodology or some other flaw in the study (or perhaps this has been done elsewhere already)?
  • 3
    A heads-up to other people trying to research this question: This study published in May 2011 was picked up by a WHO report and caused some controversy. I started to write an answer based on that until I realised it was different to the OP's study published in June 2011. Both looked at possible associations between mobile phones and gliomas.
    – Oddthinking
    Commented Jun 24, 2011 at 6:49
  • 7
    Can someone please point out for me how this study accounts for the fact that the increased proportion of cancer patients that have used cell phones are exactly the same people who are more likely to spend their entire life around other technologies and environments that could have contributed far more significantly to their risk of developing cancers?
    – Alain
    Commented Jun 24, 2011 at 19:18
  • @Alain Examples?
    – Jase
    Commented Dec 12, 2012 at 5:15
  • 1
    @Jase Cell phones do not produce ionizing radiation (for which a small link to glioma is apparent), but people who work in and around industries that do are perhaps far more likely to carry cell phones than other individuals. It makes intuitive sense, so I'm shocked they didn't even consider it as a confounding factor here, let alone collect some additional background information to test it.
    – Alain
    Commented Dec 12, 2012 at 16:30
  • 1
    Let's try not to open a new question every time a study comes out :-)
    – Sklivvz
    Commented Dec 27, 2012 at 20:59

1 Answer 1


While the Swedish study brings new data, it is inconsistent with other recent studies and suffers from similar flaws to many other studies reporting positive results

The Swedish study referred to in the question (full text available here as a pdf) is typical of many studies on the effect of mobile phone use. It uses case-control retrospective studies starting with the population of people observed to have gliomas in a particular area. It uses self-administered questionnaires on groups of diagnosed patients and on a "matching" group of non-sufferers selected to be demographically similar.

There are at least two key issues that affect the reliability of this sort of study. One is that the matching does not adequately eliminate some special characteristic of the group suffering cancer. The other is that questionnaires, especially when asking about behaviour a long time in the past, are unreliable and subject to recall bias especially in those patients seeking to blame something other than random chance for their condition. It is extremely hard to eliminate such bias and just as hard to estimate how big the bias might be. For relatively rare conditions the error bars are already large and the possibility of bias is also large.

So it is worth finding ways to test the resulting statistics for credibility in ways that avoid the particular potential sources of error. For example, what would we expect to see in a different population if the estimated effects were applied there? This has been done in a recent BMJ paper.

The BMJ paper built models of the expected rates of gliomas in the population of the USA using estimated effects based on the Swedish study and the Interphone study (which reported much lower risks than the Swedish study). They then compared the estimated incidence of gliomas to those predicted by various versions of the models (allowing for a variety of possible latency periods and so on.) Note, critically, there is no obvious trend in the population incidence of gliomas since before mobile phones became popular.

They conclude (my emphasis):

Age specific incidence rates of glioma remained generally constant in 1992-2008 (−0.02% change per year, 95% confidence interval −0.28% to 0.25%), a period coinciding with a substantial increase in mobile phone use from close to 0% to almost 100% of the US population. If phone use was associated with glioma risk, we expected glioma incidence rates to be higher than those observed, even with a latency period of 10 years and low relative risks (1.5). Based on relative risks of glioma by tumour latency and cumulative hours of phone use in the Swedish study, predicted rates should have been at least 40% higher than observed rates in 2008. However, predicted glioma rates based on the small proportion of highly exposed people in the Interphone study could be consistent with the observed data. Results remained valid if we used either non-regular users or low users of mobile phones as the baseline category, and if we constrained relative risks to be more than 1.

Raised risks of glioma with mobile phone use, as reported by one (Swedish) study forming the basis of the IARC’s re-evaluation of mobile phone exposure, are not consistent with observed incidence trends in US population data, although the US data could be consistent with the modest excess risks in the Interphone study.

The meaning of their comment on the Interphone results is that the scale of the effect seen there is not large enough to be clearly seen in the whole US population. So even if it has avoided all the biases possible in these studies, the effect is so small as to be hard to confirm and probably not large enough to worry about.

So the overall conclusion is that while some studies produce estimates of significant (though small) effects, these are not consistent with the flat incidence of gliomas in large populations where mobile phone use has skyrocketed.

You must log in to answer this question.

Not the answer you're looking for? Browse other questions tagged .